Clinical Trial

Mechanisms for Laser-Induced Rejuvenation

Recruiting
View on ClinicalTrials.gov →
Summary
It has shown that laser wounding of geriatric skin protects it against skin cancer. The purpose of this study is to determine the origin of cells called fibroblasts which are present after treatment with Fractionated Laser Resurfacing (FLR). These cells restore a youth-like ultraviolet B (UVB) response, but where they come from is currently unknown. The study recruits subjects who are scheduled to undergo abdominoplasties to investigate the origin of those cells stimulated by laser treatment.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-06-28; most recent amendment 2026-05-18.
Status change: Not Yet Recruiting → Recruiting 2026-05-18
Trial Details
NCT Number NCT06489301
Lead Sponsor Wright State University
Conditions Skin Cancer
Enrollment 12 participants
Start Date 2025-07-16
Primary Completion 2028-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-22